5E The Intersection of Policy, Science and Population Health: Pulling on the Levers of Industry, Economics and Political Will for STD Prevention

Friday, September 23, 2016: 8:00 AM-9:15 AM
Salon E
important role in many areas of public health. This session will explore these issues in service to STD prevention. The first presentation focuses on how nutrition, injury and cancer prevention have long recognized the important role that industries play as a determinant of health and have addressed them through a variety of strategies. It also explores how STD prevention can do the same, and what role science and policy can play in addressing industries such as dating sites and apps, alcohol, and the adult film industry. The second presentation explores the value of STD screening relative to other evidence based preventive services to help make the case for appropriate financial and human resource support for continuing, expanding and starting STD screening programs and policies. Using simulation modeling, the science of STD screening is translated into estimates of their population health impact and cost-effectiveness. Consistent estimation methods were applied to a wide range of evidence-based preventive services to create a valid ranking of relative value. The ranking facilitates comparison of the value of STD preventive services to other widely recognized and commonly delivered preventive care. Finally, the third presentation highlights how the science of HIV has resulted in powerful tools for prevention sensitive, rapid tests for HIV, simplified treatment regimens to hasten and maintain viral suppression and effective drug regimens for Pre- and Post-exposure prophylaxis. These tools have enabled NY City and State to develop policy and fund population-based programming aimed at ending the HIV Epidemic. One major investment has been to transform the STD clinical care paradigm from one of provider of last resort for episodic care, to destination clinics which function as hubs of sexual health care including the full spectrum of HIV and other sexual health services.

8:00 AM
How Should STD Prevention Address the Businesses That Affect Our Field?
Dan Wohlfeiler, MJ, MPH, Building Healthy Online Communities, Richmond, CA
8:20 AM
How Do STD Preventive Services Compare to Other Evidence-Based Preventive Interventions?
Michael Maciosek, PhD, HealthPartners Institute, Minneapolis, MN
8:40 AM
Impact of Changing HIV Policy on STD Clinics in NYC
Sue Blank, MD, MPH, Bureau of STD Control and Prevention, New York City Department of Health and Mental Hygiene, Long Island City, NY
See more of: Oral and Poster